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Diaphragmed fenestrae in the
glomerular endothelium versus
nondiaphragmed fenestrae in
the hepatic endothelium
To the Editor: In a recent issue of Kidney Interna-
tional, Ballermann [1] discussed the development of
diaphragmed fenestrae in glomerular endothelial cells.
Major similarities exist between the hepatic and the
glomerular endothelium regarding the process of fen-
estrae formation; intriguingly, an analogous controversy
about the origin of fenestrae exists in both the hepatology
and nephrology fields [2].
Hepatic endothelial fenestrae are dynamic structures
that act as a sieving barrier to control the extensive
exchange of material between the blood and the liver
parenchyma. These membrane-bound pores lack a di-
aphragm and a basal lamina is also absent (Fig. 1 A and B,
arrows), in contrast to fenestrae described in the kidney,
pancreas, and brain. Their biological relevance in various
diseases has been widely acknowledged [3].
Evidence that VEGF-induced diaphragmed fenestrae
are derived from fused caveolae has recently been accu-
mulating. It has been postulated that a similar mechanism
is used in the formation of hepatic fenestrae. Conversely,
actin disruption in hepatic endothelial cells produces an
increase in the number of fenestrae by using a distinct
structure that appears to serve as a fenestrae-forming
center (Fig. 1C) [4]. Furthermore, it is important to em-
phasize the contradictions in the data reported about the
origin of fenestrae in kidney, pancreas, and in the liver.
For example, some data either clearly or indirectly indi-
cate a possible relationship between caveolae, vesiculo-
vacuolar organelles, and (diaphragmed) fenestrae; oth-
ers suggest the opposite (reviewed in [2]). Therefore,
until this controversy is settled, no firm conclusions can be
drawn, and stating that fenestrae, whether diaphragmed
or not, correspond to fused and interconnected caveolae
should be viewed with caution and remains as an emerg-
ing research topic.
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Braet and Soon question the conclusions we have
drawn in a recent review [1] about the relationship be-
tween caveolae and fenestrae in glomerular endothelium.
They suggest that we were too hasty in stating that fen-
estrae do not represent fused caveolae.
There is little doubt about the dynamic nature of fen-
estrae. Work with liver sinusoidal endothelial cells is
particularly interesting because these cells retain very
nice sieve plate structures in culture which can change
rapidly by alterations in actin microfilament dynamics
[2]. Also, VEGF-A can induce endothelial fenestration.
Conversely, interference with VEGF-A function in re-
nal glomeruli, for instance, in preeclampsia [3] or with
podocyte VEGF-A haploinsufficiency [4] leads to an ab-
sence of glomerular fenestrae. Finally, VEGF-A seems
to induce caveolin-1–containing vesicles to fuse and to
form transendothelial cell channels [5, 6]. Such circum-
stantial evidence has suggested that fenestrae represent
fused caveolae.
However, in caveolin-1–deficient mice known to lack
caveolae altogether [7], we found glomerular endothe-
lium with fenestrae that were normal in size and den-
sity, even though no caveolin-1 and no caveolae were
observed at all [8]. In normal rat glomeruli exam-
ined for caveolin-1 localization by immunogold elec-
tron microscopy, fenestrated portions of glomerular
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Fig. 1. High magnification electron micrographs of rat hepatic endothelial fenestrae. (A) Transmission electron microscopy image of sectioned
hepatic endothelial cells in situ, showing the fenestrated, processes (arrow) and the histologic relationship with the numerous microvillous processes
of the liver parenchymal cells situated in the space of Disse. (B) Scanning electron micrograph of the fenestrated cytoplasm of hepatic endothelial
cells in vitro. Notice the fenestrae (arrow) on the cell surface. (C) Whole-mount transmission electron micrograph of the fenestrated cytoplasm
(arrow) of a hepatic endothelial cell cultured on transmission electron microscopy grids, disclosing the process of fenestrae formation. Note the
area of intermediated density from which rows of fenestrae with increasing diameter are radiating into the surrounding cytoplasm. Scale bars,
200 mm.
endothelium were completely devoid of caveolin-1, sim-
ilar to the report by Esser et al [9] for the choroid plexus
endothelium. Now, our experiments leave open the
possibility that fenestrae in other vascular beds could
represent fused caveolae, and that caveolar precursor
vesicles lacking caveolin-1 could fuse to form fenes-
trae. But if caveolae are defined as specialized plasma
membrane invaginations stabilized by caveolins, then our
findings in caveolin-deficient mice seem to prove that fen-
estrae in glomerular endothelium cannot represent fused
caveolae.
BARBARA J. BALLERMANN
Edmonton, Alberta, Canada
Correspondence to Barbara J. Ballermann, Director of Nephrology,
University of Alberta, Edmonton, Alberta, Canada.
E-mail: barbara.ballermann@ualberta.ca
REFERENCES
1. BALLERMANN BJ: Glomerular endothelial cell differentiation. Kidney
Int 67:1668–1671, 2005
2. BRAET F, WISSE E: Structural and functional aspects of liver sinusoidal
endothelial cell fenestrae: A review. Comp Hepatol 1:1, 2002
3. MAYNARD SE, MIN JY, MERCHAN J, et al: Excess placental soluble
fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dys-
function, hypertension, and proteinuria in preeclampsia. J Clin Invest
111:649–658, 2003
4. EREMINA V, SOOD M, HAIGH J, et al: Glomerular-specific alterations
of VEGF-A expression lead to distinct congenital and acquired renal
diseases. J Clin Invest 111:707–716, 2003
5. VASILE E, QU H, DVORAK HF, et al: Caveolae and vesiculo-
vacuolar organelles in bovine capillary endothelial cells cultured
with VPF/VEGF on floating Matrigel-collagen gels. J Histochem Cy-
tochem 47:159–167, 1999
6. YOKOMORI H, ODA M, YOSHIMURA K, et al: Vascular endothelial
growth factor increases fenestral permeability in hepatic sinusoidal
endothelial cells. Liver Int 23:467–475, 2003
7. RAZANI B, ENGELMAN JA, WANG XB, et al: Caveolin-1 null mice are
viable but show evidence of hyperproliferative and vascular abnor-
malities. J Biol Chem 276:38121–38138, 2001
8. SORENSSON J, FIERLBECK W, HEIDER T, et al: Glomerular endothelial
fenestrae in vivo are not formed from caveolae. J Am Soc Nephrol
13:2639–2647, 2002
9. ESSER S, WOLBURG K, WOLBURG H, et al: Vascular endothelial growth
factor induces endothelial fenestrations in vitro. J Cell Biol 140:947–
959, 1998
Immunosuppressive and
calcimimetic drug-drug
interactions
To the Editor: Drug-drug interactions (DDIs) are an
important cause of adverse drug reactions. It has been es-
timated that approximately 5% of prescribing errors [1]
or of adverse drug reactions [2] are caused by DDIs in
